N-Ethylmaleimide-Sensitive Factor-dependent alpha -SNAP Release, an Early Event in the Docking/Fusion Process, Is Not Regulated by Rab GTPases*

Maria I. ColomboDagger §, S. Courtney GelbermanDagger , Sidney W. Whiteheart, and Philip D. StahlDagger

From the Dagger  Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri 63110 and the  Department of Biochemistry, University of Kentucky College of Medicine, Chandler Medical Center, Lexington, Kentucky 40536

    ABSTRACT
Top
Abstract
Introduction
Procedures
Results
Discussion
References

The N-ethylmaleimide-sensitive factor (NSF) is required for multiple intracellular vesicle transport events. In vitro biochemical studies have demonstrated that NSF, soluble NSF attachment proteins (SNAPs), and SNAP receptors form a 20 S particle. This complex is disassembled by the ATPase activity of NSF. We have studied particle disassembly in a membrane environment by examining the binding of recombinant SNAPs and NSF to endosomal membranes. We present evidence that alpha -SNAP is released from the membranes in a temperature- and time-dependent manner and that this release is mediated by the ATPase activity of NSF. Our results indicate that NSF mutants in the first ATP binding domain completely abrogate alpha -SNAP release, whereas no inhibitory effect is observed with a mutant in the second ATP binding domain. Interestingly, neither beta -SNAP nor gamma -SNAP are released by the ATPase activity of NSF, indicating that these proteins are retained on the membranes by interactions that differ from those that retain alpha -SNAP. Although the small Rab GTPases are known to play a role in SNARE complex assembly, our results indicate that these GTPases do not regulate the NSF-dependent release of alpha -SNAP.

    INTRODUCTION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

The molecular mechanisms driving movement of proteins between compartments have been unraveled, in part, by the development of cell-free assays that reconstitute various transport and fusion events. Multiple membrane fusion events depend on NSF,1 the N-ethylmaleimide-sensitive factor (for a review see Refs. 1-4) that was originally identified as a protein required for Golgi transport (5). NSF has been shown to be essential for intracellular transport between the endoplasmic reticulum and Golgi (6, 7), from the Golgi to the plasma membrane (8, 9), homotypic vacuole fusion (10), transcytosis (11) and fusion among endosomes (12-14), as well as endocytosis in yeast (15). Recently, NSF also has been found to be involved in exocytosis and neurotransmitter release (2, 16-19).

Membrane association of NSF requires accessory proteins termed alpha -, beta -, and gamma -SNAPs (soluble NSF attachment proteins) (20, 21). alpha - and gamma -SNAPs function synergistically and are widely distributed among tissues, whereas beta -SNAP seems to be a brain specific isoform of alpha -SNAP. SNAPs bind to SNAREs (SNAP receptors), specific proteins present in the vesicle and in the target membrane. A set of SNAREs from bovine brain extracts was first identified by Rothman and colleagues (22). These receptors are the neuronal proteins synaptobrevin or VAMP (vesicle associated membrane protein), syntaxin and SNAP 25 (synaptosomal associated protein of 25 kDa) involved in synaptic transmission (for a review see Ref. 23). In vitro biochemical studies have demonstrated that NSF, SNAPs, and SNAREs form a 20 S complex (22, 24) that is proposed to function in vesicle targeting, docking, or fusion. To form a stable 20 S particle, a nonhydrolyzable analog of ATP, e.g. ATPgamma S, is required. In the presence of ATP, hydrolysis of this nucleotide by the ATPase activity of NSF results in the dissociation of the 20 S complex into its component subunits (22). Although the significance of this disassembly remains controversial, an attractive possibility is that the energy of ATP hydrolysis drives a conformational change in one or more of the SNARE proteins. It is important to emphasize that even though NSF is widely recognized as an essential factor in multiple transport events this protein's exact function is still unknown.

SNARE complex disassembly has been studied mainly using recombinant purified components and detergent extracts (22, 25, 26). To gather further insight into the molecular mechanism of particle disassembly in a membrane environment, we studied the binding of recombinant SNAPs and NSF to endosomal membranes. We present evidence that alpha -SNAP is released from the membranes in a temperature- and time-dependent manner and that this release is mediated by the ATPase activity of NSF. Our results indicate that certain NSF mutants (in the first ATP binding domain) completely abrogate alpha -SNAP release, whereas no inhibitory effect is observed with another NSF mutant (in the second ATP binding domain). Interestingly, neither beta -SNAP nor gamma -SNAP were released by the ATPase activity of NSF, indicating that these proteins are retained on the membranes by interactions that are different from those that retain alpha -SNAP. Our results also indicate that NSF-dependent release of alpha -SNAP is not regulated by GTPases.

    EXPERIMENTAL PROCEDURES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Cells and Materials-- J774 E-clone (mannose receptor positive), a macrophage cell line, was grown to confluence in minimum essential medium containing Earle's salts and supplemented with 10% fetal calf serum. Cytosol from J774 was the high speed supernatant of a cell homogenate obtained as described (27, 28) and stored at -80 °C. Cytosol samples (200 µl) were gel filtered through 1-ml G-25 Sephadex spin columns just before use in the fusion assay. Protein concentration after filtration was 3-5 mg/ml. Recombinant NSF wild type and mutants were prepared and purified essentially as described (29, 30). Recombinant alpha -, beta -, and gamma -SNAPs were prepared and purified as described previously (31). The monoclonal antibody, CI 77.1 antialpha /beta SNAP, was a generous gift from Dr. Reinhard Jahn (Yale University, New Haven, CT). All other chemicals were obtained from Sigma.

Preparation of Endosomal Membranes-- J774 macrophages (1 × 108 cells) were washed sequentially with 150 mM NaCl, 5 mM EDTA, 10 mM phosphate buffer, pH 7.0, and with 250 mM sucrose, 0.5 mM EGTA, 20 mM Hepes-KOH, pH 7.0 (homogenization buffer) and homogenized in the latter buffer (2 ml) using a cell homogenizer (28). Homogenates were centrifuged at 800 × g for 5 min to eliminate nuclei and intact cells. Postnuclear fractions were pelleted for 1 min at 37,000 × g in a Beckman L 100 centrifuge. The supernatants were centrifuged for an additional 5 min at 50,000 × g. The pellets of this second centrifugation were enriched with 5 min endosomes. Endosomal fractions were washed with homogenization buffer to remove cytosolic proteins, pelleted again and resuspended in the same buffer. The samples (200-µl aliquots) were frozen quickly in liquid nitrogen and stored at -80 °C.

NSF/SNAP Binding to Endosomes-- Endosomal fractions (200-µl aliquot) were thawed quickly, diluted with homogenization buffer containing 1 M KCl, and supplemented with trypsin inhibitor and p-amidinophenylmethylsulfonyl fluoride hydrochloride as protease inhibitors. Samples were incubated for 10 min at 4 °C followed by a 5-10 min incubation period at 37 °C to remove endogenous NSF and SNAP. The stripped endosomal fractions were collected by centrifugation at 45,000 rpm for 15 min using a TL 100 rotor (Beckman). The membranes (15 µg/tube) were incubated in the same buffer (250 mM sucrose, 0.5 mM EGTA, 20 mM Hepes-KOH, pH 7.0, 1 mM dithiothreitol, 1.5 mM MgCl2, 50 mM KCl, 1 mM ATP, 8 mM creatine phosphate, 31 units/ml creatine phosphokinase) used in a standard endosome fusion assay (27, 28) containing a mixture of protease inhibitors. Binding assays were carried out in fusion buffer in a final volume of 30 µl supplemented with 100 nM recombinant NSF and/or SNAPs. In some assays, the ATP-regenerating system was replaced by an ATP-depleting system (5 mM mannose, 25 units/ml hexokinase). Proteins were bound to the membranes for 5-10 min at 4 °C. Subsequently, membranes were incubated for 20 min at either 4 or 37 °C to study the effect of temperature on the release of bound proteins. After incubation, the endosomal membranes were washed with 1 ml of homogenization buffer and sedimented by centrifugation. In some experiments, the samples were centrifuged to separate bound proteins (pellet) from unbound proteins (supernatant). Membrane pellets were solubilized in SDS-polyacrylamide gel electrophoresis sample buffer. Proteins were separated by SDS-polyacrylamide gel electrophoresis and transferred onto nitrocellulose membranes using standard techniques. NSF was detected by Western blot analysis with the mouse monoclonal antibody 6E6 (32) at a 1:500 dilution. NSF-truncated mutants were detected with both the monoclonal antibody 6E6 and an additional rabbit polyclonal anti-NSF. alpha /beta -SNAPs were detected using the monoclonal antibody CI 77.1 (26) at a dilution of 1:10,000, whereas gamma -SNAP was detected using a rabbit polyclonal antibody generated against the whole recombinant protein. Visualization was performed with a horseradish peroxidase rabbit anti-mouse (1:5,000) or horseradish peroxidase-coupled goat anti-rabbit antibody (1:2,000) with the Lumiglo chemiluminescence reagents (Pierce) according to the manufacturer's instructions.

    RESULTS
Top
Abstract
Introduction
Procedures
Results
Discussion
References

NSF-dependent Release of alpha -SNAP Requires ATP Hydrolysis-- It has been shown previously that ATP hydrolysis by NSF disassembles the SNARE complex (22, 25). However, the formation and disruption of this complex has been studied mainly with recombinant purified components and detergent extracts (22, 25, 26, 44, 45). To gain further insight into the molecular mechanism involved in particle disassembly in a membrane environment, we studied the binding of recombinant SNAPs and NSF to endosomal membranes. For this purpose, an endosomal fraction was prepared as described under "Experimental Procedures." The membranes were incubated with 1 M KCl in homogenization buffer to strip off the endogenous peripheral membrane-associated proteins. Membranes then were incubated in fusion buffer supplemented with recombinant NSF and/or alpha -SNAP for 5-10 min at 4 °C to allow for binding of the proteins. Subsequently, the samples were incubated for an additional 20 min at either 4 or 37 °C. The endosomal membranes were then sedimented by centrifugation, and bound proteins were detected by Western blotting. Because alpha -SNAP binds to plastic tubes (35), we precoated all of the tubes used in the binding experiments with 10% ovalbumin in phosphate-buffered saline. Very little binding of alpha -SNAP and NSF was detected when ovalbumin-coated tubes were incubated with these proteins in the absence of endosomal membranes (data not shown).

Endosomal membranes were incubated with 100 nM alpha -SNAP in the presence (Fig. 1A, lanes 2 and 4) or the absence (lanes 1 and 3) of recombinant NSF. Neither NSF nor alpha -SNAP were detected (data not shown) in membranes incubated in fusion buffer in the absence of added proteins, indicating that the endogenous proteins were removed by the high salt treatment. Fig. 1, panel A shows that when the membranes were incubated in the presence or absence of recombinant NSF at 4 °C, alpha -SNAP remained bound to the endosomal fraction (Fig. 1, lanes 1 and 2). In samples incubated for 20 min at 37 °C, after the initial binding at 4 °C, alpha -SNAP remained bound to the membranes only in the absence of added NSF (lane 3). In contrast, in the presence of NSF, almost no bound alpha -SNAP was detected (lane 4). A concomitant increase in alpha -SNAP was found in the supernatant (data not shown), indicating alpha -SNAP release from the membranes. These results suggest that NSF mediates the release of alpha -SNAP in a temperature-dependent fashion.


View larger version (34K):
[in this window]
[in a new window]
 
Fig. 1.   NSF releases alpha -SNAP in a temperature-dependent manner. An enriched endosomal membrane fraction was incubated for 10 min at 37 °C with 1 M KCl in homogenization buffer to strip off the endogenous peripheral membrane-associated proteins. Panel A, membranes were incubated in fusion buffer supplemented with recombinant alpha -SNAP (100 nM) in the presence or absence of 100 nM NSF for 5-10 min at 4 °C to allow binding of the proteins. Subsequently, the samples were incubated for an additional 20 min at either 4 or 37 °C. Panel B, endosomal membranes were incubated with recombinant NSF and alpha -SNAP as indicated in panel A for 5-10 min at 4 °C and then incubated for different periods of time at 37 °C. After incubation, the endosomal membranes were washed with 1 ml of homogenization buffer and sedimented by centrifugation. The bound proteins were separated by SDS-polyacrylamide gel electrophoresis and transferred onto nitrocellulose membranes. NSF and alpha -SNAP were detected by Western blot analysis using mouse monoclonal antibodies. Data represent one of three independent experiments.

Interestingly, we observed that in samples incubated at 37 °C, most of alpha -SNAP was released from the membranes, whereas only a fraction of NSF was released. Quantification by densitometry indicates that while approximately 80% of alpha -SNAP was released, only 45% of NSF was released under the same experimental conditions. Moreover, a substantial amount of NSF bound to the endosomal membrane fraction in the absence of added alpha -SNAP (data not shown). It is possible that this binding was due to aggregated inactive NSF. Using the in vitro endosome fusion assay, our results indicate that NSF bound to membranes in the absence of alpha -SNAP is active and capable of restoring endosome fusion activity in N-ethylmaleimide-treated endosomes (data not shown). To determine whether or not NSF was interacting with a protein factor, the endosomal fraction was either heat-inactivated or preincubated for 40-60 min at room temperature with proteinase K (0.7 mg/ml) in the presence of a small amount of Triton X-100 (0.002%). Both treatments result in almost complete inhibition of NSF binding in the absence of alpha -SNAP, indicating that NSF associates with a protein factor (data not shown).

To study the kinetics of NSF-mediated alpha -SNAP release, we analyzed the retention of proteins after incubating membranes at 37 °C for different periods of time. Fig. 1, panel B shows that after a 5 min incubation period at 37 °C, a significant amount of alpha -SNAP was released. After 20 min, the release was almost complete, while a substantial amount of NSF still remained associated with the membranes.

Next, we studied the nucleotide requirement for the process. As shown in Fig. 2, panel A, in the presence of NSF and an ATP-regenerating system, nearly complete release of alpha -SNAP was observed (lane 1). This release was abrogated by an ATP-depleting system (lane 2) or by ATPgamma S (lane 3). These results are consistent with earlier data using isolated purified proteins and suggest that in our system NSF drives the release of alpha -SNAP in a process that requires ATP hydrolysis. Since it has been shown that NSF has ATPase activity, it is likely that ATP hydrolysis by NSF catalyzes the release of alpha -SNAP from the membranes. NSF is a homotrimer of 76-kDa subunits that contains an amino-terminal domain and two homologous ATP-binding domains (32, 36). Mutants of NSF have been produced in which either the ATP binding or ATP hydrolysis of each nucleotide-binding region was altered (29, 37). In a recent report, we have shown that mutations in the first ATP binding domain of NSF block endosome fusion (14). To rule out the possibility that another ATPase present on the endosomal fraction is involved in alpha -SNAP release and to confirm the requirement of NSF's ATPase activity in the process, we tested the effect of NSF mutants in the binding assay. As shown in Fig. 2, panel B, D1EQ, an NSF construct with a point mutation in the first ATP binding domain lacking ATPase activity, and D1KA, a mutant that does not bind ATP, completely blocked alpha -SNAP release. In contrast, D2DQ, a construct with a point mutation in the second ATP binding domain of NSF, permitted alpha -SNAP release to an extent similar to that permitted by wild-type NSF (Fig. 3, lane 5), indicating that the second ATP-binding domain of NSF is not required for the NSF-mediated release of alpha -SNAP. As expected, the isolated amino-terminal domain of NSF (N fragment) and a truncated NSF molecule lacking the D1 domain (ND2) did not release alpha -SNAP (Fig. 3, lanes 6 and 8). These results indicate that the ATPase activity of the D1 domain of NSF is absolutely required for the NSF-dependent release of alpha -SNAP. Interestingly, although the ND1 truncated form contains the D1 domain, this mutant was unable to release alpha -SNAP (lane 7). The lack of activity observed with this truncated protein is not surprising as the ND1 mutant, although capable of dissociating an in vitro SNAP-SNARE complex, binds to this complex with a much lower affinity than wild-type NSF (30).


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 2.   alpha -SNAP release requires ATP hydrolysis and is blocked by NSF mutants. Panel A, an enriched endosomal fraction was incubated for 20 min at 37 °C in the presence of 100 nM recombinant NSF and alpha -SNAP. RS, ATP-regenerating system (8 mM creatine phosphate, 31 units/ml creatine phosphokinase) including 1 mM ATP; DS, an ATP-depleting system (5 mM mannose, 25 units/ml hexokinase); ATPgamma S, 20 µM ATPgamma S was added to the binding assay. Panel B, endosomal membranes were incubated as above in the presence of 1 mM ATP and an ATP-regenerating system. Recombinant alpha -SNAP and either wild-type NSF or the NSF mutants D1EQ and D1KA (100 nM each) were added to the binding assay. Bound proteins were detected as described in Fig. 1. Data represent one of four independent experiments.


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 3.   The first ATP binding domain of NSF is absolutely required for alpha -SNAP release. High salt-washed endosomal membranes were incubated with 100 nM alpha -SNAP and either 100 nM wild-type NSF (NSFwt), the NSF mutants D1EQ, D1KA, and D2DQ or the following truncated forms of NSF (30): N, a 25-kDa fragment corresponding to the amino-terminal domain of NSF; ND1, a 61.6-kDa protein lacking the second ATP binding domain; ND2, a 57.4-kDa protein lacking the first ATP binding domain. Bound proteins were detected as described in Fig. 1. Data represent one of three independent experiments.

NSF Regulates alpha -SNAP but not beta - or gamma -SNAP Release-- Three different forms of SNAPs, alpha -, beta - and gamma -SNAP (35, 36 and 39 KDa, respectively), have been purified from bovine brain (21). alpha - and gamma -SNAP are widely distributed among tissues, whereas beta -SNAP seems to be a brain specific isoform of alpha -SNAP (alpha - and beta -SNAP are 83% identical to each other). Therefore, we were interested in determining whether beta - and gamma -SNAP were released from the membranes in a manner similar to that of alpha -SNAP. As shown in Fig. 4, panel A, neither beta -SNAP nor gamma -SNAP were released from the membranes by the ATPase activity of NSF, suggesting that they are retained by the membranes through interactions that are different from those that retain alpha -SNAP. Interestingly, when alpha -SNAP and gamma -SNAP were added together, alpha -SNAP was released by wild-type NSF while gamma -SNAP remained bound (Fig. 4, panel B). This result suggests that, in contrast to what is observed in the in vitro particle disassembly reaction (35), gamma -SNAP is not released by the ATPase activity of NSF when monitored in a membrane environment.


View larger version (39K):
[in this window]
[in a new window]
 
Fig. 4.   NSF regulates alpha -SNAP but not beta - or gamma -SNAP release. Panel A, endosomal membranes were incubated in the presence of 1 mM ATP and an ATP-regenerating system. Recombinant alpha -, beta -, or gamma -SNAPs were added to the binding assay. Samples were supplemented with wild-type NSF (NSFwt), D1EQ, or D1KA (100 nM each) as indicated. Bound proteins were detected as described in Fig. 1. Data represent one of three independent experiments. Panel B, membranes were supplemented with wild-type NSF, alpha -, and gamma -SNAP. Samples were incubated either at 4 or 37 °C. Bound proteins were detected as described in Fig. 1. Data represent one of three independent experiments.

NSF-dependent Release of alpha -SNAP Is Not Regulated by Rab GTPases-- Genetic interactions and biochemical studies have demonstrated that Rab proteins, a class of small GTPases, play a role in the assembly of specific SNARE complexes (38, 39). We were interested in determining the role of GTPases in the NSF-mediated release of alpha -SNAP. For this purpose, salt-washed endosomal membranes were preincubated for 30 min at 25 °C in the absence (control) or presence of 100 µM GDPbeta S or GTPgamma S. Samples then were incubated for 20 min at either 4 or 37 °C in fusion buffer containing 100 nM alpha -SNAP with or without recombinant NSF. Fig. 5, panel A shows that neither GDPbeta S nor GTPgamma S blocked the NSF-mediated release of alpha -SNAP.


View larger version (50K):
[in this window]
[in a new window]
 
Fig. 5.   NSF-dependent release of alpha -SNAP is not regulated by Rab GTPases. Panel A, high salt-washed endosomal membranes were preincubated in the absence (control) or in the presence of 100 µM GDPbeta S or GTPgamma S. Membranes were then supplemented with 100 nM alpha -SNAP with or without recombinant NSF, incubated for 10 min at 4 °C to allow the binding of the proteins, and subsequently incubated for 20 min at either 4 or 37 °C. Panel B, endosomal membranes were preincubated for 30 min at 25 °C under the following conditions: control, no additions; GDP, in the presence of 1 mM GDP; GDP + GDI, in the presence of 1 mM GDP and 10 µM recombinant Rab GDP-dissociation inhibitor (GDI). Samples were then supplemented with alpha -SNAP with or without recombinant NSF as described in panel A. Samples were processed as described in Fig. 1, and bound proteins were detected by Western blotting. Data represent one of three independent experiments.

Next, we examined the effect of recombinant GDI (Rab GDP dissociation inhibitor), which is known to remove Rab proteins specifically from membranes (40, 41). The endosomal fraction was preincubated for 30 min at 25 °C in the absence (control) or presence of 1 mM GDP and 10 µM GDI. Samples were supplemented with 100 nM alpha -SNAP with or without recombinant NSF and subsequently were incubated for 20 min at either 4 or 37 °C. Fig. 5, panel B shows that preincubation of the membranes with GDI did not affect the NSF-driven release of alpha -SNAP, suggesting that Rab proteins do not regulate the disassembly process.

    DISCUSSION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

An important conceptual highlight regarding the molecular machinery involved in intracellular transport and neurotransmitter release came from the discovery of the SNAREs (for a review see Ref. 42), membrane receptors for SNAP (22). NSF binds through SNAPs to a complex of neuronal proteins comprised of synaptobrevin, syntaxin, and SNAP 25. Disassembly of this complex by NSF occurs in the presence of ATP and is thought to be critical for membrane fusion not only at the synaptic level but also in intracellular transport events (reviewed in Refs. 1, 3, 4, and 42).

In the present report, we present evidence that alpha -SNAP is released from the membranes in a temperature- and time-dependent manner. This release is absolutely dependent on the ATPase activity of NSF, as mutations in NSF that render the protein defective in either ATP binding or hydrolysis result in almost complete inhibition of alpha -SNAP release. Our data indicate that the release of alpha -SNAP takes place after a few minutes of incubation at 37 °C and is almost complete by 15-20 min. Our results agree with those of Wickner and collaborators (43) showing that Sec18p (yeast NSF homologue) drives the release of Sec17p (yeast alpha -SNAP homologue) after a short incubation at 37 °C. Interestingly, we have observed previously that endosome fusion becomes insensitive to NSF mutants after 15 min (14). However, at that point only 20% of the total measurable fusion has occurred. Therefore, alpha -SNAP is released long before the fusion reaction is complete. Both results are consistent with the idea of an early action for NSF. This hypothesis receives independent support from studies in regulated exocytosis that show NSF acting at a prefusion ATP-dependent step but not at the Ca2+ triggered fusion step (16, 18). The recent finding that Sec18p/Sec17p are required in a priming step before the actual docking event (44) provides additional support for the idea that NSF is required for early steps.

NSF·SNAP·SNARE complex formation requires the presence of ATP, and disassembly is driven by conditions that favor ATP hydrolysis (22). It has been shown that in the presence of ATP NSF bound to syntaxin through alpha -SNAP catalyzes a conformational change in the syntaxin molecule that induces the release of both NSF and alpha -SNAP (26). However, most of these studies have been carried out with recombinant proteins and/or detergent extracts (22, 25, 26, 33, 34). Our binding studies with membranes indicate that upon incubation with Mg2+-ATP most alpha -SNAP is released, whereas NSF is released only partially from the membranes. These data suggest that although part of NSF is bound to membranes in an alpha -SNAP-dependent manner there is a fraction of NSF that is retained by the membranes through an alpha -SNAP-independent mechanism. However, this NSF binding in the absence of SNAP was sensitive to proteinase K and heat treatment, indicating that NSF associates with a protein factor perhaps distinct from the classical NSF/SNAP receptors. Our results are consistent with the observations of Mayer et al. (43). They showed that in yeast, although the release of Sec17p is rapid and complete, little Sec18p is released from the membranes. This finding indicates that Sec18p must be bound to the membranes via a protein distinct from Sec17p. Moreover, in a recent publication, it has been shown that Sec18p (yeast NSF) binds to GST-Pep12p, a putative yeast SNARE, in a Sec17p (yeast SNAP) independent manner (45). Interestingly, Woodman and co-workers have shown that treatment of coated vesicles with Mg2+-ATP did not result in release of NSF (46). Therefore, it appears that NSF is retained on coated vesicles by interactions that are different from the classical NSF·SNAP·SNARE complexes. In addition, it has been shown previously that NSF associated with synaptic vesicles (47) and with growth cones (48) was not released upon incubation with Mg2+-ATP. Considered together, these results indicate that in the presence of Mg2+-ATP there is a pool of NSF that remains associated with membranes perhaps in an alpha -SNAP independent manner.

In contrast to alpha -SNAP, neither beta -SNAP nor gamma -SNAP were released from the membranes by the ATPase activity of NSF, suggesting that they are retained by interactions that are different from those that retain alpha -SNAP. Indeed, it has been shown that beta -SNAP unlike alpha -SNAP binds synaptotagmin and recruits NSF (49). In agreement with our data, this complex is unaffected by Mg2+-ATP. Interestingly, when alpha - and gamma -SNAP were added together, alpha -SNAP was released by NSF whereas gamma -SNAP was not released. Although cross-linking experiments indicate that alpha - and gamma -SNAP interact directly when bound to membranes (31), it is possible that this interaction is transient and occurs only under certain experimental conditions (e.g. in the absence of Mg2+-ATP). Moreover, it has been shown that gamma -SNAP binds to a different membrane receptor protein or at a site that is distinct from the alpha /beta -SNAP-binding site (34, 35). This differential interaction is consistent with our observation that the nearly complete release of alpha -SNAP from membranes is not accompanied by gamma -SNAP release.

Among the proteins that have been implicated in the regulation of intracellular membrane transport are the members of the Rab family of monomeric GTPases (for review see Refs. 50-53). Although Rab proteins do not seem to be core components of the SNARE complex, genetic evidence supports a role for the Rab proteins in the assembly of this complex (38, 39). In addition, evidence for a functional link between Rab3 and the SNARE complex has been presented recently (54). Our data indicate that NSF-driven release of alpha -SNAP is not regulated by GTPases. Therefore, although complex assembly relies on Rab function, it is likely that the NSF-mediated disassembly does not. Our results are consistent with previous results showing that the release of sec17p in yeast was not influenced by GTPgamma S or by antibodies against the Rab protein homologue Ypt7p (43).

We believe that binding studies using a membrane environment, such as those described in this report, should prove to be useful models for further biochemical analyses and for the identification of other molecules that regulate the assembly and disassembly of the docking/fusion machinery.

    ACKNOWLEDGEMENTS

We thank Drs. Phyllis Hanson and Carmen Alvarez-Dominguez for critical reading of this manuscript. We thank Dr. Chun Zhi Yang for kindly providing purified GDI and for advice regarding the proper use of this protein. We also are grateful to Moges Taddese and Aysel Monniae for technical assistance.

    FOOTNOTES

* This work was supported in part by a National Institutes of Health grant (to P. D. S.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ To whom correspondence should be addressed: Instituto de Histología y Embriología, Facultad de Ciencias Médicas, Universidad Nacional de Cuyo-CONICET, Mendoza, Argentina. Tel.: 54-61-205-115 (ext. 2670); Fax: 54-61-494-117.

1 The abbreviations used are: NSF, N-ethylmaleimide-sensitive factor; SNAP, soluble NSF attachment protein; SNARE, SNAP receptor; GTPgamma S, guanosine 5'-3-O-(thio)triphosphate; GDPbeta S, guanosine 5'-O-2-(thio)diphosphate; GDI, GTP dissociation inhibitor; ATPgamma S, adenosine 5'-O-(thiotriphosphate).

    REFERENCES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

  1. Whiteheart, S. W., and Kubalek, E. W. (1995) Trends Cell Biol. 5, 64-68 [CrossRef]
  2. Morgan, A. (1996) Nature 382, 686
  3. Söllner, T. (1995) FEBS Lett. 369, 80-83[CrossRef][Medline] [Order article via Infotrieve]
  4. Pfeffer, S. R. (1996) Annu. Rev. Cell Dev. Biol. 12, 441-461 [CrossRef][Medline] [Order article via Infotrieve]
  5. Block, M. R., Glick, B. S., Wilcox, C. A., Wieland, F. T., Rothman, J. E. (1988) Proc. Nat. Acad. Sci. U. S. A. 85, 7852-7856[Abstract]
  6. Beckers, C. J. M., Block, M. R., Glick, B. S., Rothman, J. E., Balch, W. E. (1989) Nature 339, 397-398[CrossRef][Medline] [Order article via Infotrieve]
  7. Rexach, M. F., and Schekman, R. W. (1991) J. Cell Biol. 114, 219-229[Abstract]
  8. Graham, T. R., and Emr, S. D. (1991) J. Cell Biol. 114, 207-218[Abstract]
  9. Ikonen, E., Tagaya, M., Ullrich, O., Montecucco, C., and Simons, K. (1995) Cell 81, 571-580[Medline] [Order article via Infotrieve]
  10. Haas, A., and Wickner, W. (1996) EMBO J. 15, 3296-3305[Abstract]
  11. Sztul, E., Colombo, M. I., Stahl, P. D., Samanta, R. (1993) J. Biol. Chem. 268, 1876-1885[Abstract/Free Full Text]
  12. Diaz, R., Mayorga, L. S., Weidman, P. J., Rothman, J. E., Stahl, P. D. (1989) Nature 339, 398-400[CrossRef][Medline] [Order article via Infotrieve]
  13. Rodriguez, L., Stirling, C. J., and Woodman, P. G. (1994) Mol. Biol. Cell 5, 773-783[Abstract]
  14. Colombo, M. I., Taddese, M., Whiteheart, S. W., Stahl, P. D. (1996) J. Biol. Chem. 271, 18810-18816[Abstract/Free Full Text]
  15. Hicke, L., Zanolari, B., Pypaert, M., Rohrer, J., and Riezman, H. (1997) Molec. Biol. Cell 8, 13-31[Abstract]
  16. Chamberlain, L. H., Roth, D., Morgan, A., and Burgoyne, R. D. (1995) J. Cell Biol. 130, 1063-1070[Abstract]
  17. Morgan, A., and Burgoyne, R. D. (1995) EMBO J. 14, 232-239[Abstract]
  18. Banerjee, A., Barry, V. A., DasGupta, B. R., Martin, T. F. J. (1996) J. Biol. Chem. 271, 20223-20226[Abstract/Free Full Text]
  19. Pallanck, L., Ordway, R. W., Ramaswami, M., Chi, W. Y., Krishnan, K. S., Ganetzky, B. (1995) J. Biol. Chem. 270, 18742-18744[Abstract/Free Full Text]
  20. Weidman, P. J., Melancon, P., Block, M. R., Rothman, J. E. (1989) J. Cell Biol. 108, 1589-1596[Abstract]
  21. Clary, D. O., Griff, I. C., and Rothman, J. E. (1990) Cell 61, 709-21[Medline] [Order article via Infotrieve]
  22. Söllner, T., Whiteheart, S., Brunner, M., Erdjument-Bromage, H., Geromanos, S., Tempst, P., and Rothman, J. E. (1993) Nature 362, 318-324[CrossRef][Medline] [Order article via Infotrieve]
  23. Südhof, T. C. (1995) Nature 375, 645-653[CrossRef][Medline] [Order article via Infotrieve]
  24. Wilson, D. W., Whiteheart, S. W., Wiedmann, M., Brunner, M., and Rothman, J. E. (1992) J. Cell Biol. 117, 531-538[Abstract]
  25. Hayashi, T., Yamasaki, S., Nauenburg, S., Binz, T., and Niemann, H. (1995) EMBO J. 14, 2317-2325[Abstract]
  26. Hanson, P. I., Otto, H., Barton, N., and Jahn, R. (1995) J. Biol. Chem. 270, 16955-16961[Abstract/Free Full Text]
  27. Diaz, R., Mayorga, L. S., and Stahl, P. (1988) J. Biol. Chem. 263, 6093-6100[Abstract/Free Full Text]
  28. Colombo, M. I., Lenhard, J. M., Mayorga, L. S., Stahl, P. D. (1992) Methods Enzymol. 219, 32-44[Medline] [Order article via Infotrieve]
  29. Whiteheart, S. W., Rossnagel, K., Buhrow, S. A., Brunner, M., Jaenicke, R., Rothman, J. E. (1994) J. Cell Biol. 126, 945-954[Abstract]
  30. Nagiec, E. E., Bernstein, A., and Whiteheart, S. W. (1995) J. Biol. Chem. 270, 29182-29188[Abstract/Free Full Text]
  31. Whiteheart, S. W., Griff, I. C., Brunner, M., Clary, D. O., Mayer, T., Buhrow, S. A., Rothman, J. E. (1993) Nature 362, 353-355[CrossRef][Medline] [Order article via Infotrieve]
  32. Tagaya, M., Wilson, D. W., Brunner, M., Arango, N., and Rothman, J. E. (1993) J. Biol. Chem. 268, 2662-2666[Abstract/Free Full Text]
  33. McMahon, H. T., and Südhof, T. C. (1995) J. Biol. Chem. 270, 2213-2217[Abstract/Free Full Text]
  34. Kee, Y., Lin, R. C., Hsu, S.-C., and Scheller, R. H. (1995) Neuron 14, 991-998[Medline] [Order article via Infotrieve]
  35. Whiteheart, S. W., Brunner, M., Wilson, D. W., Wiedmann, M., Rothman, J. E. (1992) J. Biol. Chem. 267, 12239-12243[Abstract/Free Full Text]
  36. Wilson, D. W., Wilcox, C. A,., Flynn, G. C., Chen, E., Kuang, W. J.., Henzel, W. J., Block, M. R., Ullrich, A., Rothman, J. E. (1989) Nature 339, 355-359[CrossRef][Medline] [Order article via Infotrieve]
  37. Sumida, M., Hong, R.-M., and Tagaya, M. (1994) J. Biol. Chem. 269, 20636-20641[Abstract/Free Full Text]
  38. Søgaard, M., Tani, K., Ye, R. R., Geromanos, S., Tempst, P., Kirchhausen, T., Rothman, J. E., Söllner, T. (1994) Cell 78, 937-948[Medline] [Order article via Infotrieve]
  39. Lian, J. P., Stone, S., Jiang, Y., Lyons, P., and Ferro-Novick, S. (1994) Nature 372, 698-701[CrossRef][Medline] [Order article via Infotrieve]
  40. Soldati, T., Riederer, M., and Pfeffer, S. R. (1993) Mol. Biol. Cell 4, 425-434[Abstract]
  41. Ullrich, O., Horiuchi, H., Bucci, C., and Zerial, M. (1994) Nature 368, 157-160[CrossRef][Medline] [Order article via Infotrieve]
  42. Rothman, J. E., and Warren, G. (1994) Curr. Biol. 4, 220-233[Medline] [Order article via Infotrieve]
  43. Mayer, A., Wickner, W., and Haas, A. (1996) Cell 85, 83-94[Medline] [Order article via Infotrieve]
  44. Mayer, A., and Wickner, W. (1997) J. Cell Biol. 136, 307-317[Abstract/Free Full Text]
  45. Burd, C. G., Peterson, M., Cowles, C. R., Emr, S. D. (1997) Mol. Biol. Cell 8, 1089-1104[Abstract]
  46. Steel, G. J., Tagaya, M., and Woodman, P. G. (1996) EMBO J. 15, 745-752[Abstract]
  47. Hong, R.-M., Mori, H., Fukui, T., Moriyama, Y., Futai, M., Yamamoto, A., Tashiro, Y., and Tagaya, M. (1994) FEBS Lett. 350, 253-257[CrossRef][Medline] [Order article via Infotrieve]
  48. Tagaya, M., Furuno, A., and Mizushima, S. (1996) J. Biol. Chem. 271, 466-470[Abstract/Free Full Text]
  49. Schiavo, G., Gmachl, M. J. S., Stenbeck, G., Söllner, T. H., Rothman, J. E. (1995) Nature 378, 733-736[CrossRef][Medline] [Order article via Infotrieve]
  50. Novick, P., and Brennwald, P. (1993) Cell 75, 597-601[Medline] [Order article via Infotrieve]
  51. Zerial, M., and Stenmark, H. (1993) Curr. Opin. Cell Biol. 5, 613-620[Medline] [Order article via Infotrieve]
  52. Nuoffer, C., and Balch, W. E. (1994) Annu. Rev. Biochem. 63, 949-990[CrossRef][Medline] [Order article via Infotrieve]
  53. Pfeffer, S. R. (1994) Curr. Opin. Cell Biol. 6, 522-526[Medline] [Order article via Infotrieve]
  54. Johannes, L., Doussau, F., Clabecq, A., Henry, J.-P., Darchen, F., and Poulain, B. (1996) J. Cell Sci. 109, 2875-2884[Abstract/Free Full Text]


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.